2015
20/12/2015
December Newsletter 2015
30/11/2015
Proteomics International Presents PromarkerD at IDF 2015 – Vancouver World Diabetes Congress
20/11/2015
Shareholder Presentation – Annual General Meeting
18/11/2015
Proteomics International receives R&D Tax Incentive
Find out more →
09/11/2015
Proteomics International featured in AusIndustry Business News Monthly
Innovative diabetic diagnosis recognised
03/11/2015
Managing director, Dr Richard Lipscombe Presents at the Australasian Life Science and Healthcare Showcase 2015 in Seoul
30/10/2015
Proteomics International Invited to Attend the 6th China International Medical Expo
27/10/2015
US Patent granted for Predictive and Diagnostic Test for Diabetic Kidney Disease
Find out more →
26/10/2015
Proteomics Technical Presentation
Find out more →
26/10/2015
Translating biomarker discovery into a diagnostic test for diabetic kidney disease
Find out more →
25/10/2015
Managing director, Dr Richard Lipscombe Presents at the 11th Australian Peptide Conference 2015
25/10/2015
11th Australian Peptide Conference
19/10/2015
Proteomics International wins WA Industry and Export Award
Find out more →
09/10/2015
The West Australian
Proteomics International is nominated as a finalist in the export category of West Australia’s Industry and Export Awards.
02/09/2015
Investor Presentation – AusBiotech
01/09/2015
Winter Newsletter 2015
19/08/2015
Investor Presentation – Canary Networks
09/06/2015
Ground-breaking Predictive Test for Diagnosis of Diabetic Kidney Disease
Find out more →
01/06/2015
Investor Presentation – June 2015
19/05/2015
Global Head of Business Development appointed
Find out more →
28/04/2015
Proteomics International secures significant biosimilars contract
Find out more →
23/04/2015
Proteomics International secures major contract with The a2 Milk Company
Find out more →
16/04/2015
Proteomics International goes public
Find out more →
16/04/2015
Proteomics International lists on ASX
Find out more →
02/04/2015
Proteomics International successfully closes IPO
Find out more →
03/03/2015
The Australian
The Human Genome Project represents the single largest undertaking in the history of biological science. Providing investors with cutting-edge exposure to this emerging field [proteomics] is the coming listing of PILL.
16/02/2015
Proteomics International to commercialise DKD test in China
Find out more →
04/02/2015
Interview with our Managing Director
Wholesale Investor interviews PILL’s Richard Lipscombe on the company’s past and future.
01/02/2015
Summer Newsletter 2015
25/01/2015
BioSpectrum Asia
Trends & Responses 2015: Proteomic Laboratories
09/01/2015
Supplementary Prospectus issued
Find out more →
Newsroom
Private: In the Media
Presentations
Newsletters
Publications
Events
News Archive
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
Subscribe
Title
Name
*
Position
Company/Organisation
*
Phone
Email
*
Terms & Conditions
*
I accept the terms and conditions
Comments
This field is for validation purposes and should be left unchanged.
Company
About Us
Board
Mission Statement
Senior Staff
Quality
Customer Testimonials
Careers
Glossary
PromarkerD
Diagnostics
Biomarker Discovery
The Promarker™ Pipeline
Analytical Services
Pharmacokinetic Testing
Biosimilars/Biologics Drug Characterisation
Proteome Mapping
Proteome Quantitation (iTRAQ, TMT, Label-Free)
Targeted Mass Spectrometry (MRM/SRM)
Protein ID by Mass Spectrometry
Post-translational Modifications (PTMs)
Additional Services
Project Consultation
Pricing and Ordering
Terms and Conditions
FAQs
Newsroom
Top Stories
Media Releases
Media Coverage
Videos
Science & Technology
Presentations
Newsletters
Publications
Events
Investors
Share Price and Analyst Coverage
ASX Announcements
Corporate Media
Corporate Presentations
Library
Reports
Corporate Governance
Annual General Meeting
Contact
Sample Delivery
Technical
Business Development
Agents